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ABSTRACT
The immune system plays a vital role in cancer therapy, especially with the
advent of immunotherapy. Radiation therapy induces iatrogenic immunosuppression
referred to as radiation-induced lymphopenia (RIL). RIL correlates with significant
decreases in the overall survival of cancer patients. Although the etiology and severity
of lymphopenia are known, the mechanism(s) of RIL are largely unknown. We found
that irradiation not only had direct effects on circulating lymphocytes but also had
indirect effects on the spleen, thymus, and bone marrow. We found that irradiated
cells traffic to the bone marrow and bring about the reduction of hematopoietic
stem cells (HSC) and progenitor cells. Using mass cytometry analysis (CyTOF) of the
bone marrow, we found reduced expression of CD11a, which is required for T cell
proliferation and maturation. RNA Sequencing and gene set enrichment analysis of the
bone marrow cells following irradiation showed down-regulation of genes involved in
hematopoiesis. Identification of CD11a and hematopoietic genes involved in iatrogenic
immune suppression can help identify mechanisms of RIL.

INTRODUCTION

to the T-cells from radiation will reduce the number of
T-cells in circulation which should be repopulated in 80–
90 days. However, RIL persists six months to a year after
irradiation [3, 7] which is far beyond the T-cell turnover
time suggesting an indirect mechanism may be involved
in immune suppression.
Previously we found that autologous transplantation
of hematopoietic stem cells after irradiation rescued
mice from RIL [8]. A similar approach was successful
in overcoming chemotherapy-induced lymphopenia.
Autologous hematopoietic stem cell reinfusion to
lymphopenic patients with either advanced myeloma [9] or
metastatic breast cancer [10] after high dose chemotherapy
achieved the recovery of lymphocytes.
Previous studies have focused on the direct effect
of radiation on T-cells [5, 6]. Our central hypothesis is

The immune system plays an important role
in keeping us healthy from pathogens and foreign
bodies including cancer cells. Immune system plays
an important role in cancer therapy especially with the
advent of immunotherapy [1]. Radiation causes iatrogenic
immunosuppression referred to as Radiation-induced
lymphopenia (RIL), which correlates with treatment
outcomes and survival of cancer patients [2–4]. RIL is
associated with poor outcome for many cancers, including
lung, colon, pancreas, and breast [2–4]. An improved
understanding of the biological mechanisms of the
persistence of RIL is needed.
Previous studies have implicated the direct effects of
radiation on lymphocyte depletion [5, 6]. Direct damage
www.oncotarget.com

1681

Oncotarget

that long-term RIL involves not only T-cells but also
indirect effects on hematopoietic stem cells. To study these
phenomena, we utilized CyTOF and RNA sequencing to
identify the changes in the bone marrow after irradiation.
We also analyzed the T and B cells from blood-forming
organs that include blood, spleen, thymus, and bone marrow.
We found that irradiation affects the T-cells and
B-cells in the spleen, thymus, and bone marrow. We also
found cellular and transcriptome changes in the bone
marrow compartment of mice in response to thoracic IR.
This study identified depletion the of CD11a expression
in the HSC and progenitor cells in the bone marrow and
downregulation of expression of hematopoiesis genes in
the bone marrow stem cells.

showed a significant reduction in the size (Supplementary
Figure 2B) and weight (88.9 mg vs. 32.3 mg; P ≤ 0.0001;
Supplementary Figure 2C).
To study the effects of radiation on thymus, we
irradiated the mouse thorax and head (1.8Gy ×5) and
analyzed the thymus of the mice. T cell progenitors evolve
into thymocytes in the Thymus. The T cell development
in the thymus takes place in three broad phases that are
controlled by two developmental checkpoints. The phases
are distinguished based on the CD4/CD8 expression status.
The earliest thymocytes are double negative or DN phase
(DN1, DN2, and DN3) where the thymocytes express
neither CD4 nor CD8. As the thymocytes mature, they
express both CD4 and CD8 called the double positive or
DP phase. The thymocytes then undergo thymic selection
to commit to either the CD4 or CD8 lineage referred to
as single positive or the SP phase [11]. After irradiation
to the thorax and analysis of the thymus, we found a
significant reduction in DP (4.99E+07 vs. 5.06E+06 P
≤ 0.001) and DN (1.7E+06 vs. 7.7E+05; P ≤ 0.001) cell
populations (Figure 1F). In our stepwise analysis of the
thymus, we found that all populations of DN1 (4.68E+04
vs. 5.56E+04 P = 0.998), DN2 (2.06E+04 vs. 9.61E+03
P = 0.997), and DN3 (7.42E+05 vs. 4.42E+05 P = 0003),
also reduced after thoracic irradiation (Figure 1G). We also
found a significant reduction in the size (Supplementary
Figure 2D) and weight (Supplementary Figure 2E) of the
thymus (89.5 mg vs. 33.9 mg; P ≤ 0.0003) after thoracic
irradiation. Similarly analysis of the thymus after radiation
to the head also, showed significant reduction in DP
(3.90E+07 vs. 2.26E+06 P ≤ 0.001) and DN (9.16E+05
vs. 3.83E+05; P = 0.966) cell populations (Figure 1H).
In our stepwise analysis of the thymus, we found that all
populations of DN1 (9.50E+04 vs. 2.32E+04 P = 0.193),
DN2 (1.55E+04 vs. 2.66E+04 P = 0.986), and DN3
(3.46E+05 vs. 4.43E+04 P ≤ 0.0001), also reduced after
irradiation (Figure 1I). These results indicate that IR has
direct and indirect effects on T and B cells in lymphoid
organs in addition to circulating in blood.

RESULTS
Irradiation depletes cells in blood, spleen, and
thymus
To determine the effect of radiation on the lymphoid
organs, we analyzed the blood, spleen, and thymus after
irradiation. The C57BL/6 mice were irradiated with 5
doses of 1.8 Gy to the thorax or head, and sham-irradiated
mice served as controls (Figure 1A and Supplementary
Figure 1). The blood and spleen were analyzed for CD3+,
CD4+, CD8+ T cells, and CD19+ B cells using flow
cytometry 24 h post final irradiation. T cells (for cellmediated, cytotoxic adaptive immunity), and B cells (for
humoral, antibody-driven adaptive immunity) are the
main types of cells found in the blood. After irradiation
to the thorax, we found a significant reduction in the
circulating CD3 (4.18E+02 vs. 9.00E+01; P ≤ 0.0001),
CD4 (2.59E+02 vs. 6.06E+01; P ≤ 0.0001), CD8
(9.14E+01 vs. 1.36E+01; P = 0.011) and CD19 (3.58E+02
vs. 7.99E+01; P ≤ 0.0001) cells in the blood (Figure 1B).
After irradiation to the head, we found a significant
reduction in the circulating CD3 (3.71E+02 vs. 7.64E+01;
P ≤ 0.0001), CD4 (1.88E+02 vs. 4.63E+01; P ≤ 0.0003),
CD8 (1.37E+02 vs. 1.51E+01; P = 0.0012) and CD19
(3.08E+02 vs. 9.23E+01; P ≤ 0.0001) cells in the blood
(Figure 1C).
The spleen is a secondary lymphoid organ that plays
an important role in clearing the damaged cells and plays
an important role in the adaptive immune response. After
irradiation to thorax, we found a significant reduction in
CD3 (7.71E+04 vs. 4.81E+04; P ≤ 0.001), CD4 (4.19E+04
vs. 1.38E+04; P ≤ 0.001), CD8 (2.60E+04 vs. 6.11E+03;
P ≤ 0.001) and CD19 (1.03E+05 vs. 4.35E+04; P ≤
0.001) cells in the spleen (Figure 1D). After irradiation
to the head, we found a significant reduction in CD3
(1.71E+05 vs. 1.03E+05; P ≤ 0.001), CD4 (3.21E+04 vs.
6.56E+03; P ≤ 0.002), CD8 (1.72E+04 vs. 2.36E+03; P
≤ 0.02) and CD19 (2.09E+05 vs. 1.20E+05; P ≤ 0.006)
cells in the spleen (Figure 1E). Analysis of the spleen
following thoracic irradiation (Supplementary Figure 2A)
www.oncotarget.com

Irradiation depletes cells in the bone marrow
Earlier, we found that long-term lymphopenia is
mainly caused by the depletion of hematopoietic stem
cells [8]. To determine the indirect effect of radiation
on bone marrow, we analyzed Lineage−/lowSca-1+cKit+ (LSK) signaling lymphocyte activation molecules
(SLAM), long-term hematopoietic stem cells (LT-HSC),
common lymphoid progenitor (CLP), common myeloid
progenitor (CMP), megakaryocyte erythroid progenitor
(MEP) and granulocyte-monocyte progenitor (GMP) cells
in bone marrow after irradiation. The C57BL/6 mice were
irradiated with 5 doses of 1.8 Gy to the thorax, head, and
sham-irradiated mice served as controls (Figure 2A). The
mice were irradiated to the thorax or the head and the bone
marrow was not directly irradiated.
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We found reduction in hematopoietic stem cells
LSK-SLAM in thorax irradiated (7.13E+03 vs. 2.36E+03;
P ≤ 0.0001), and head irradiated (4.26E+02 vs. 1.20E+02;
P ≤ 0.0001) mice. We also found reduction in LT-HSC
in thorax irradiated (1.13E+03 vs. 4.97E+02; P ≤ 0.0001)
and head irradiated (9.90E+01 vs. 3.97E+01; P ≤ 0.0001)
mice (Figure 2B and 2C).
We found reduction in lymphoid progenitors CLP
in thorax irradiated (6.82E+04 vs. 2.55E+04; P = 0.035),
and head irradiated (6.76E+05 vs. 2.34E+05; P ≤ 0.0001)
mice. We also found reduction in myeloid progenitors
CMP in thorax irradiated (3.05E+06 vs. 1.44E+06; P ≤
0.0001) and head irradiated (1.01E+05 vs. 9.82E+03; P =
0.035) mice (Figure 2D and 2E).
We found reduction in late hematopoietic
progenitors MEP in thorax irradiated (1.05E+06 vs.
7.48E+05; P = 0.0119), and head irradiated (5.99E+03 vs.
9.15E+02; P ≤ 0.0001) mice. We also found reduction in
GMP in thorax irradiated (1.12E+07 vs. 5.24E+06; P =
0.648) and head irradiated (3.42E+04 vs. 5.99E+03; P =

0.0025) mice (Figure 2F and 2G). These results indicate
that there is an indirect mechanism of depletion of CLP
and CMP in the bone marrow following thoracic and head
IR.

Ex-vivo irradiated PBCs traffic to the bone
marrow
To determine if irradiated peripheral blood cells
traffic to the bone marrow, we isolated peripheral blood
cells (PBC) from 200µl of mouse blood, labeled them
with a fluorescent membrane dye, DiD and irradiated with
sham or 6 Gy irradiation. The PBCs stained with DiD were
injected autologously to the mice (Figure 3A). The bone
marrow cells were analyzed for hematopoietic stem cells
(Lin-Sca1+ckit+CD34-, HSCs) and the hematopoietic
progenitor cells (Lin-Sca1+ckit+CD34+, HPCs) at 24
h post autologous injection (Figure 3A). We observed a
decrease in both HSC (6 vs. 1.6 cells; ns = 0.7015) and the
HPC (46 vs. 14.6 cells; P = 0.0009) in the mice injected

Figure 1: Radiation depletes cells in blood, spleen, and thymus. Schematic representation of the treatment plan for mice (A).

The mouse thorax or head was irradiated with 1.8 Gy for 5 days consequently. The blood, spleen and thymus from the mice were analyzed
1 day post irradiation, untreated mice were used as controls. Irradiation depletes CD3, CD4, CD8 and CD19 in the blood (B, C) and spleen
(D, E). Irradiation depletes double positive (DP) and double negative (DN) populations (F, G) along with DN1, DN2, and DN3 populations
(H, I) in thymus. SD are from at least three treatments.
www.oncotarget.com
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with ex-vivo irradiated peripheral blood mononuclear cells
(PBMCs) when compared to sham-irradiated PBMCs
(Figure 3B). Therefore we next studied whether ex-vivo
irradiated PBMCs and/or EVs traffic to the bone marrow
and fuse with HSCs and HPCs. We analyzed the presence
of the DiD marker on the HSCs and HPCs. We found
an increase in the number of DiD+HSC (3 vs. 0.6; ns
P = 0.084) and DiD+HPCs (9 vs. 1.3; P ≤ 0.0001) in the
mice injected with irradiated PBMCs compared to sham
controls (Figure 3C). The presence of DiD within HSCs
and HPCs indicates that ex vivo treated blood cells could
be trafficking to the bone marrow and bring about its
reduction.

treated mice on day 1 and day 10 after the last fractionated
radiation dose. We also isolated bone marrow cells from
untreated mice as sham controls (Figure 4A). Following
CyTOF acquisition, the data were analyzed using viSNE
clustering (Cytobank). Various population clusters were
manually gated in the tSNE1/2 fields, and we identified
the differences between treated and untreated mice using
the density plots. Figure 4B shows the manual gates on
three clusters, which show significant changes on day 1
and day 10, compared to sham. We observed a reduction in
cluster 1 at day 1 (2.0%) and day 10 (4.7%) after irradiation
when compared to sham (6.8%). We observed a reduction
in cluster 2 at day 1 (1.7%) and increase on day 10 (9.2%)
after irradiation when compared to sham (4.2%). Cluster
3 was upregulated at day 1 (14.3%) and day 10 (9.7%)
compared to sham irradiation (7.5%).
The same viSNE maps were then assessed for
the median expression of CD11a (Figure 4C). The
bar diagrams show the fold change in the median
expression of the indicated markers. CD11a was almost
2-fold downregulated on Day 1 compared to sham
mice (Figure 4D). We further validated CD11a in a
separate set of mice using flow cytometry. We observed
a reduction in CD11a expression in hematopoietic stem
cells after irradiation. We found an average of 84 cells/
million in irradiated mice when compared to 150/million
(P = 0.0075) cells in the untreated control (Figure 4E). To
determine if the CD11a cells were undergoing apoptosis

Irradiation depletes CD11a expressing cells in
the bone marrow
To study the changes in cell phenotypes in the bone
marrow compartment after irradiation, we performed
mass cytometry analysis in a Cytometry by Time of Flight
(CyTOF). CyTOF uses metal-conjugated antibodies that
allow for high-throughput analysis of a large number of
parameters on single cells [12]. We developed custom mass
cytometry panels that include lymphoid, myeloid, and NK
cell lineage, the details are listed in Supplementary Table 1.
We irradiated C57BL/6 mice with five fractions of 1.8Gy in
thorax region after shielding the rest of the body. We then
isolated the bone marrow cells from the femurs of these

Figure 2: Radiation depletes hematopoietic stem cells and progenitor cells in the bone marrow. Schematic representation

of the treatment plan for mice (A). The mouse thorax or head were irradiated with 1.8 Gy for 5 consecutive days. The cells from the bone
marrow were analyzed using flow cytometry 24 h post final irradiation. Irradiation depleted the LT-HSC and LSK-SLAM cells after
thoracic irradiation (B) and head irradiation (C) total cells when compared to sham mice. Irradiation also depleted both common lymphoid
progenitor cells (CLP) and common myeloid progenitor cells (CMP) after thoracic irradiation (D) and head irradiation (E). Irradiation
depleted the megakaryocyte erythroid progenitor (MEP) and granulocyte-monocyte progenitor (GMP) after thoracic irradiation (F) and
head irradiation (G). SD from at least three treatments.
www.oncotarget.com
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after IR, we analyzed the bone marrow cells with PARP
assay. We found that IR may have induced apoptosis in
the bone marrow cells but it was not significantly different
from untreated mice (Figure 4F). We then analyzed for
cells expressing CD11a being mobilized in circulation
after IR (Figure 4G). We found that IR induced the
mobilization of CD11a cells from the bone marrow into
circulation after IR. At 4h we found that IR led to an initial
increase in CD11a cells in circulation (P = 0.20), which
later stabilized at 24 h, 48 h and 72 h. At 96 h post IR, we
found that there was a significant increase of CD11a cells
in circulation, which remained significantly elevated even
at 216 h (Figure 4G).

discovery ratio) of < 0.25. The enrichment score (ES)
reflects the degree to which a gene set is over-represented
in the data set. The normalized enrichment score (NES)
is the ES normalized for gene set size. The normalized
enrichment score (NES) for the hematopoiesis genes was
1.7715 with a nominal p-value < 0.0001 (Figure 6). The
hematopoiesis genes Hoxa9, Hoxa4, FLT3, HSPALL,
and BCL2, were downregulated. The data suggest that
hematopoiesis genes are downregulated in bone marrow
in response to irradiation of thorax.

DISCUSSION
Immunotherapy utilizes a patient’s own immune
system to treat cancer and is at the forefront of cancer
therapy. The CD4 and CD8 effector cells that identify
and eliminate cancer cells play an essential role in cancer
immunotherapy [5]. Monoclonal antibodies that target
PD-1 or PD-L1 often referred to as checkpoint inhibitors
are used to treat various cancers, including melanoma [14],
non-small cell lung cancer [15], kidney cancer, bladder
cancer, head and neck cancers, and Hodgkin lymphoma.
Radiation therapy (RT), which is an integral
part of cancer management, causes radiation-induced
lymphopenia (RIL). RIL is a significant clinical problem
affecting treatment outcome and survival of cancer
patients [2–4]. Persistence of RIL is associated with poor
outcome for several carcinomas, including lung, colon,
pancreas breast, sarcomas, and glioblastoma [2, 16].
The proposed mechanisms of RIL include
secretion of galectin-1 from tumors but not from the host
microenvironment or healthy tissues [6]. Studies with our
mouse model showed RIL is independent of the site of
irradiation, which is in agreement with the clinical data [3,
4, 8]. Unlike previous studies focusing on the direct effect
of radiation on T-cells [5, 6]; we studied indirect effects on
hematopoietic stem cells.
In this study, we used an innovative discovery
platform and characterized the indirect effect of radiation
on HSC. Within the BM, we identified the changes at
the molecular level and cellular level. We found that the
irradiated cells traffic to the bone marrow and deplete
HSC and progenitor cells. These results support the model
that RIL results from the indirect effect of radiation on the
lymphocytes and stem cells in the bone marrow in addition
to the direct effect on circulating lymphocytes.
We further evaluated thymus and spleen to gain a
better understanding how secondary lymphoid organs
respond to radiation. We found a significant reduction
in the T-cells and B-cells in secondary lymphoid organs
such as spleen and thymus. Our analysis revealed that both
primary and secondary lymphoid organs are affected by
radiation further supporting the idea that RIL results from
the indirect effect of radiation on lymphoid organs.
Previously we found that lymphopenia is mainly
caused by depletion of hematopoietic stem cells in the

Irradiation causes transcriptome changes in the
unirradiated bone marrow compartment
To identify the transcriptional changes in the bone
marrow compartment after irradiation, we utilized highthroughput RNA sequencing (RNA-Seq). Briefly, the mice
were irradiated with 5 doses of 1.8 Gy to the thorax, and
sham-irradiated mice served as controls (Figure 5A). The
mRNA was isolated from bone marrow cells using the
miRVANA kit (Ambion). We performed GO analysis of the
RNA-seq data and found that 858 genes changed after day
1 and 295 genes changed after day10 following irradiation
when compared with untreated controls. We also observed
that the expression of 1051 genes altered in the unirradiated
bone marrow after irradiation from day 1 to day 10
(Figure 5B). On comparing day 1 to sham in the GO analysis,
we found almost 4-fold upregulation of Golgi vesicle
transport and DNA repair genes and downregulation of genes
involved in both innate and adaptive immune response, T
cell activation, antigen processing, and presentation and other
indicated GO processes (Figure 5D). Figure 5C shows the
–log 10 p-values of the GO biological processes indicated in
Figure 5D. The mean log fold change of the GO biological
processes at day 10 compared to sham and day 10 compared
to day 1 are shown in Supplementary Figure 3. Specifically,
on day 10 compared to sham, we observed downregulation of
genes that regulate vasculature development, angiogenesis,
and Rho protein signaling amongst other signaling pathways.

Molecular pathways regulated by radiation in
bone marrow
To identify molecular pathways and evaluate specific
gene expression changes, we used Gene Set Enrichment
Analysis (GSEA). GSEA analysis of three treatment
groups (sham, day1, and day 10 following irradiation) was
performed as described previously [13]. Differential gene
expression profiles were generated for thousands of genes
using RNA-seq data from sham (n = 3) versus day1 (n = 3)
and day 10 (n = 3). Gene sets with member genes enriched
in sham were discovered. Statistically significant gene sets
were considered with a P-value < 0.05 and FDR (false
www.oncotarget.com
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bone marrow [8]. In this study we further analyzed the
bone marrow cells using CyTOF. Using CyTOF we found
a reduction in CD11a expression in hematopoietic stem
cells after irradiation when compared to sham irradiation.

CD11a plays a significant role in the migration of
lymphocytes and T cell development and is critical for
the generation of common lymphoid progenitors (CLPs)
[17]. The reduced expression of CD11a due to the indirect

Figure 3: Ex-vivo irradiated PBCs traffic to the bone marrow. Schematic representation of the treatment plan for mice (A). 200
µl of the whole blood was irradiated ex vivo (mice were not irradiated), and the cells were labeled with DiD and reinfused autologously
into unirradiated mice. (B). Ex-vivo irradiated blood induces reduction of hematopoietic stem cells and progenitor cells in mouse bone
marrow. (C). DiD-labeled hematopoietic stem cells increase in the bone marrow following ex-vivo irradiation of blood. SD from at least
three treatments.

Figure 4: CyTOF analysis of bone marrow cells following irradiation. (A) Schematic representation of the treatment of mice

prior to mass cytometry analysis (CyTOF) of the bone marrow compartment. Mouse thorax was irradiated, and the cells from femurs of
mice were harvested day 1 and day 10 after irradiation, untreated mice were used as controls. (B) Representative density plots of lineage
negative bone marrow cells in the tSNE1/tSNE2 fields following CyTOF acquisition. (C) Lineage-negative bone marrow cells in the tSNE1/
tSNE2 fields displaying the median expression of CD11a. Color scale indicates the intensity of expression of CD11a. Minimum (min) and
maximum (max) correspond to the 2nd and the 98th percentile values for each indicated marker, respectively. (D) Bar graph indicating the
fold change in CD11a expression on Day 1 and Day 10 following thoracic IR. (E) Flow cytometry analysis of the bone marrow compartment
following thoracic IR to validate the results of mass cytometry. The bar graph representing the counts of CD11a+ stem cells in the bone
marrow. SD from at least three treatments. (F) Flow cytometry analysis of the bone marrow compartment following thoracic IR to evaluate
for apoptosis. The bar graph representing the percentage of PARP positive cells in the bone marrow. SD from at least three treatments. (G)
Irradiation mobilizes the cells expressing CD11a from the bone marrow into the circulation. The mouse thorax were irradiated (1.8 Gy ×5)
and the cells expressing CD11a from the circulating blood were analyzed using flow cytometry at the time points indicated.
www.oncotarget.com
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radiation could be (i) mobilizing the CD11a cells from
the bone marrow into circulation (ii) preventing the
development of lymphoid progenitor cells in the bone
marrow, (iii) preventing mobilization of pre-T cells to
the thymus, and (iv) preventing T-cell development in the
Thymus. We found mobilization of CD11a cells from the
bone marrow into circulation.
To identify the transcriptional changes of
hematopoietic stem cells after irradiation, we utilized highthroughput RNA sequencing (RNA-Seq). We identified
and quantitated gene expression changes (transcriptome
changes) after irradiation. We used Gene set enrichment
analysis (GSEA) to identify classes of genes that are overrepresented in a broad set of associated genes. GSEA uses
statistical approaches to identify significantly enriched or
depleted groups of genes (http://software.broadinstitute.
org/gsea/index.jsp). We found that hematopoiesis genes
were down-regulated after radiation. The CyTOF analyses
and bulk RNA-seq profiling indicated that pathways
involved in immune regulation are drastically impacted
after irradiation. This study identified potential candidates
like CD11a and hematopoiesis genes like Hoxa9, Hoxa4,

FLT3, HSPALL, and BCL2. These genes could play a
potential role in iatrogenic immunosuppression. Future
studies with defined genetic models will be required to
answer these questions comprehensively.

MATERIALS AND METHODS
Reagents and antibodies
All antibodies for flow cytometry were from BD
Biosciences (USA). APC-Cy7-CD3, FITC-CD4, PerCPCy5.5-CD8, and V450-CD19 antibodies were used to stain
blood. BM mononuclear cells were stained with PerCPCy5.5 conjugated lineage markers (Mac-1, Gr-1, B220,
CD3, and Ter119), PE-Sca-1, APC-Cy7-c-kit, APC-Flt3,
and FITC-CD34.

Irradiations
All studies were performed in accordance with
the guidelines of the Institutional Animal Care and
Use Committee and with protocols approved by the

Figure 5: Gene Ontology (GO) analysis to identify differentially regulated genes. (A) Schematic representation of the treatment

plan. Mouse thorax were irradiated, and the cells from femurs of mice were harvested day 1 and day 10 after irradiation, untreated mice
were used as controls. The RNA-sequence analysis was performed on RNA obtained from these bone marrow cells. (B) Gene Ontology
(GO) analysis was performed to identify differentially regulated mRNAs. Venn diagram showing the number of significantly enriched
mRNAs in the indicated groups. (C) Bar graph showing –log10 P-values of the GO biological processes on day 1 compared to sham mice.
(D) Bar graph showing the mean log fold change of the GO biological processes shown in panel C. SD from at least three treatments.
www.oncotarget.com
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Washington University Division of Comparative
Medicine. Six to eight week old female C57BL/6 mice
were obtained from Charles River. Mice were anesthetized
with 2% isoflurane prior to irradiations to the thorax or
the head (Supplementary Figure 1). The mice were
irradiated with 1.8 Gy/day for five consecutive days. In
some experiments, 200 µl of blood was drawn from mice,
irradiated with one dose of 6 Gy ex vivo, and re-injected
autologously to the respective mice. Mice and blood were
irradiated using RS-2000 (Rad Source) irradiator at a dose
rate of 1 Gy/min with 160 kVp X-rays.

(Miltenyi Biotec) and data analyzed with FlowJo software
(Tree Star Inc.).

DiD staining
We isolated peripheral blood cells (PBCs) from 200
µl of mouse blood, resuspended the PBCs in autologous
plasma and irradiated them ex-vivo. The irradiated PBCs
in plasma were incubated overnight at 37ºC. For tracking
experiments, cells were labeled with a fluorescent
membrane dye, Vybrant DiD (ThermoFisher Scientific)
according to the manufacturer’s instructions.

Flow cytometry

Mass cytometry (CyTOF)

The peripheral blood cells and splenocyte cells from
various treatments were stained with anti- CD16/32, CD3,
CD4, CD8, and CD19 antibodies. For thymocytic cells
CD117, CD44, CD25, CD127, CD3, CD4 and CD8 were
used to stain different population. Hematopoietic stem
and progenitor cells were stained with lineage markers
as described earlier [18]. We used following antibodies:
CD117, Ly-6A/E, CD34, CD135, CD127, CD48, CD150
and CD16/32 from BD biosciences and Mac-1, Gr-1,
CD4, CD8, B220, CD3, and Ter119 from Biolegend. Cells
were analyzed by MACSQuant Analyzer flow cytometer

Metal-tagged antibodies were purchased from
Fluidigm or custom-conjugated using the Maxpar ×8
Antibody Labeling Kit as per manufacturer’s instructions
(Fluidigm). All custom-conjugated antibodies were titrated.
For staining, 3 × 106 bone marrow cells were stained with
surface antibodies (Supplementary Table 1) for 1 h at 4°C
in CyFACS buffer (0.1% BSA, 0.02% NaN2, 2 mM EDTA
in CyPBS, Rockland). Cells were stained for viability
with 2.5 μM cisplatin (Enzo life sciences) according to a
standard protocol [19, 20]. Cells were washed three times

Figure 6: GSEA analysis revealed downregulation of genes involved in hematopoiesis. Mouse lungs were irradiated, and

the cells from femurs of mice were harvested day 1 and day 10 after irradiation, untreated mice were used as controls. The RNA-sequence
analysis was performed on RNA obtained from these bone marrow cells. Gene Set Enrichment Analysis (GSEA) analysis was performed
using RNA-seq data and gene sets for the mouse. Enrichment plot shows the nominal P value and NES for hematopoiesis. Heat map
showing the gene expression changes of the top 30 genes after irradiation. Hematopoiesis genes are down-regulated after irradiation when
compared to unirradiated control. SD from at least three treatments.
www.oncotarget.com
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treatment groups were performed using moderated t-test. A
p-value of < 0.05 was considered statistically significant.
These analyses were performed in Prism 7 (GraphPad
Software, La Jolla, CA, USA), and statistical significance
was indicated in each graph where appropriate.

and stained with Cell-ID intercalator according to the
manufacturer’s instructions (Fluidigm).
Data were analyzed using viSNE (Cytobank), with
uniform sampling, 10% down-sampling, and clustered on
the parameters shown in Supplementary Table 1. Using
the density plots, various populations were gated in the
tSNE1/2 fields. The viSNE-gated populations were then
assessed for the median expression of indicated markers,
as well as percent positive for the indicated markers.
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RNA-Seq
Mice were irradiated with 5 doses of 1.8 Gy to
the thorax, and sham-irradiated mice served as controls.
The bone marrow cells were harvested from femurs by
flushing them with 1 ml of PBS at days 1 and 10 following
IR. The mRNA was isolated from bone marrow cells
using the miRVANA kit (Ambion). RNA sequencing
was performed by Genome Technology Access Center
(GATC), Washington University in St. Louis. Gene
counts were derived from the number of uniquely aligned
unambiguous reads by Subread: feature Count version
1.4.5. Transcript counts were produced by Sailfish version
0.6.3. Sequencing performance was analyzed for a total
number of aligned reads, the total number of uniquely
aligned reads, genes, and transcripts detected, ribosomal
fraction known junction saturation and read distribution
over known gene models with RSeQC version 2.3.
Genes or transcripts not expressed in any sample
or less than one count-per-million in the minimum group
size minus one were excluded from further analysis.
Performance of the samples was assessed with a Spearman
correlation matrix and multi-dimensional scaling plots.
Gene/transcript performance was evaluated with plots of
residual standard deviation of every gene to their average
log-count with a robustly fitted trend line of the residuals.
Differentially expressed genes and transcripts were then
filtered for FDR adjusted p-values less than or equal to 0.05.
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